DLAT and breast cancer: These results indicate that higher DLAT expression levels are associated with a worse prognosis in patients with BC, and DLAT is relatively highly expressed in the TNBC subtype, suggesting that DLAT may have a more pronounced impact on the malignant behavior of tumors in patients with TNBC.